IPO Trending
GLANDSME / NSE, BSEListed
Gland Pharma

Founded in Hyderabad, India, in 1978, Gland Pharma has evolved from a small-scale contract manufacturer to one of the largest and fastest-growing injectable-focused companies. It has a global presence in 60 countries, including the United States, Europe, Canada, Australia, and India. Operating primarily under a B2B model, Gland Pharma has a strong track record in developing, manufacturing, and marketing complex injectables. Its integrated presence across the value chain has fueled rapid growth. The company is promoted by Shanghai Fosun Pharma, a leading global pharmaceutical company.

₹1,490 - ₹1,500Open
Listed Price₹1710.00
Listing Gain+14.00%

Subscription Status

0Updated 22 Dec 2025, 01:59 PM
Subscription PendingExchange subscription breakup is not available yet.

Category-wise demand has not been published yet. Check back after the exchange updates the live subscription feed.

Open Date09 Nov 2020
Close Date11 Nov 2020
Listing Date20 Nov 2020
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Gland Pharma IPO Subscription Demand

Live subscription status and bidding analysis for Gland Pharma (GLAND) IPO. The issue is subscribed Tracking Live overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions